JP2022520803A5 - - Google Patents
Info
- Publication number
- JP2022520803A5 JP2022520803A5 JP2021547189A JP2021547189A JP2022520803A5 JP 2022520803 A5 JP2022520803 A5 JP 2022520803A5 JP 2021547189 A JP2021547189 A JP 2021547189A JP 2021547189 A JP2021547189 A JP 2021547189A JP 2022520803 A5 JP2022520803 A5 JP 2022520803A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- dna
- nucleic acid
- itr
- rep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024064717A JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端ＤＮＡ（ｃｅＤＮＡ）の産生におけるＲＥＰタンパク質活性の調節 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806076P | 2019-02-15 | 2019-02-15 | |
| US62/806,076 | 2019-02-15 | ||
| PCT/US2020/018332 WO2020168222A1 (en) | 2019-02-15 | 2020-02-14 | Modulation of rep protein activity in closed-ended dna (cedna) production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064717A Division JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端ＤＮＡ（ｃｅＤＮＡ）の産生におけるＲＥＰタンパク質活性の調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022520803A JP2022520803A (ja) | 2022-04-01 |
| JP2022520803A5 true JP2022520803A5 (https=) | 2023-02-22 |
| JP7644014B2 JP7644014B2 (ja) | 2025-03-11 |
Family
ID=72045641
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547189A Active JP7644014B2 (ja) | 2019-02-15 | 2020-02-14 | 閉端ＤＮＡ（ｃｅＤＮＡ）の産生におけるＲＥＰタンパク質活性の調節 |
| JP2024064717A Pending JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端ＤＮＡ（ｃｅＤＮＡ）の産生におけるＲＥＰタンパク質活性の調節 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024064717A Pending JP2024083567A (ja) | 2019-02-15 | 2024-04-12 | 閉端ＤＮＡ（ｃｅＤＮＡ）の産生におけるＲＥＰタンパク質活性の調節 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220127625A1 (https=) |
| EP (1) | EP3924491A4 (https=) |
| JP (2) | JP7644014B2 (https=) |
| KR (1) | KR20210127935A (https=) |
| CN (1) | CN113454232B (https=) |
| AU (1) | AU2020221312A1 (https=) |
| CA (1) | CA3129321A1 (https=) |
| IL (1) | IL285415A (https=) |
| MA (1) | MA54958A (https=) |
| SG (1) | SG11202106491VA (https=) |
| WO (1) | WO2020168222A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ762100A (en) | 2017-08-09 | 2025-12-19 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof |
| EP3833766A1 (en) | 2018-08-09 | 2021-06-16 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof for non-viral gene therapy |
| WO2020251954A1 (en) * | 2019-06-10 | 2020-12-17 | Homology Medicines, Inc. | Adeno-associated virus compositions for arsa gene transfer and methods of use thereof |
| JP2023535632A (ja) | 2020-07-27 | 2023-08-18 | アンジャリウム バイオサイエンシズ エージー | Ｄｎａ分子の組成物、その作製方法、及びその使用方法 |
| EP4214309A4 (en) * | 2020-09-16 | 2025-07-16 | Generation Bio Co | CLOSED-END DNA VECTORS AND RELATED USES FOR EXPRESSING PHENYLALANINE HYDROXYLASE (PAH) |
| WO2022136616A1 (en) * | 2020-12-23 | 2022-06-30 | Vivet Therapeutics | Minimal bile acid inducible promoters for gene therapy |
| EP4308705A4 (en) * | 2021-03-16 | 2025-06-04 | Wisconsin Alumni Research Foundation | INSULIN GENE THERAPY TO TREAT DIABETES |
| MX2024002333A (es) * | 2021-08-23 | 2024-03-07 | Bioverativ Therapeutics Inc | Sistema de expresion de baculovirus. |
| CN114703203B (zh) * | 2022-02-11 | 2024-08-06 | 上海渤因生物科技有限公司 | 杆状病毒载体及其用途 |
| KR102737146B1 (ko) * | 2023-07-10 | 2024-12-09 | 대한민국 | 신규 발현 벡터 및 이의 용도 |
| WO2025114932A1 (en) * | 2023-11-30 | 2025-06-05 | Sanofi | Purification of closed-ended dna molecules |
| US12509711B1 (en) * | 2024-08-09 | 2025-12-30 | Martin Williams | System and process for in vivo manufacturing nanostructure-ended double-stranded covalently-closed linear DNA, the resulting molecules and their uses |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2596303C (en) * | 1997-03-21 | 2013-09-24 | Enzo Therapeutics, Inc. | Vectors and viral vectors and packaging cell lines for propagating same |
| WO2001032899A1 (en) | 1999-10-29 | 2001-05-10 | Takara Shuzo Co., Ltd. | Gene transfer method |
| CN103849629B (zh) * | 2006-06-21 | 2017-06-09 | 尤尼克尔Ip股份有限公司 | 具有经修饰的用于在昆虫细胞中产生aav的aav‑rep78翻译起始密码子的载体 |
| EP2545165B1 (en) * | 2010-03-11 | 2020-07-29 | uniQure IP B.V. | Mutated rep encoding sequences for use in aav production |
| EP2500434A1 (en) * | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| CA2942289C (en) * | 2014-03-10 | 2024-05-21 | Uniqure Ip B.V. | Further improved aav vectors produced in insect cells |
| MX2018010633A (es) * | 2016-03-03 | 2019-06-13 | Univ Massachusetts | Acido desoxirribonucleico (adn) lineal duplex de extremos cerrados para transferencia genica no viral. |
| NZ762100A (en) * | 2017-08-09 | 2025-12-19 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof |
-
2020
- 2020-02-14 CN CN202080014548.5A patent/CN113454232B/zh active Active
- 2020-02-14 MA MA054958A patent/MA54958A/fr unknown
- 2020-02-14 CA CA3129321A patent/CA3129321A1/en active Pending
- 2020-02-14 SG SG11202106491VA patent/SG11202106491VA/en unknown
- 2020-02-14 US US17/430,341 patent/US20220127625A1/en active Pending
- 2020-02-14 EP EP20756257.0A patent/EP3924491A4/en active Pending
- 2020-02-14 KR KR1020217025576A patent/KR20210127935A/ko active Pending
- 2020-02-14 AU AU2020221312A patent/AU2020221312A1/en active Pending
- 2020-02-14 WO PCT/US2020/018332 patent/WO2020168222A1/en not_active Ceased
- 2020-02-14 JP JP2021547189A patent/JP7644014B2/ja active Active
-
2021
- 2021-08-05 IL IL285415A patent/IL285415A/en unknown
-
2024
- 2024-04-12 JP JP2024064717A patent/JP2024083567A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022520803A5 (https=) | ||
| JP2022190081A5 (https=) | ||
| US11834683B2 (en) | High titer recombinant AAV vector production in adherent and suspension cells | |
| EP3436051B1 (en) | Column-based fully scalable raav manufacturing process | |
| JP2022549380A5 (https=) | ||
| JP2022516004A5 (https=) | ||
| JP2023171525A (ja) | Ａａｖキメラ | |
| JP2020532981A5 (https=) | ||
| JP2012519008A5 (https=) | ||
| JP2019533803A5 (https=) | ||
| JP2022542828A5 (https=) | ||
| HRP20192141T1 (hr) | Genska terapija za retinitis pigmentosa | |
| JP2022512621A5 (https=) | ||
| JP2022524434A5 (https=) | ||
| JP2020519284A5 (https=) | ||
| JP2022525302A5 (https=) | ||
| JP2023520763A5 (https=) | ||
| JP2025029049A5 (https=) | ||
| CN118460614A (zh) | 一种腺相关病毒Cap蛋白的表达框 | |
| JP2024503895A5 (https=) | ||
| WO2024078584A1 (zh) | 腺相关病毒的衣壳蛋白编码基因改造方法 | |
| RU2021126774A (ru) | Модуляция активности rep белка при получении днк с замкнутыми концами (зкднк) | |
| WO2024163979A2 (en) | Engineered aav polypeptides | |
| WO2025171001A1 (en) | Compositions and methods for improved production of aav viral vectors | |
| WO2025207456A1 (en) | Methods for purification of adeno associated virus particles by anion exchange chromatography |